CJC-1295 with DAC

CJC-1295 with DAC

Price range: £75.00 through £180.00

CJC-1295 with DAC by PEPTIDE MEDICS is a synthetic growth hormone–releasing hormone (GHRH) analogue widely studied in peptide research involving endocrine signaling and hormone regulation pathways. This peptide is designed with a Drug Affinity Complex (DAC) modification, which extends its activity in experimental models by increasing peptide stability.

Researchers often investigate CJC-1295 with DAC in laboratory studies examining growth hormone signaling, metabolic processes, and endocrine system interactions.

Each vial from PEPTIDE MEDICS is supplied in high-purity lyophilized form and available in 2 mg and 5 mg research vials for controlled laboratory analysis.

All peptides sold by PEPTIDE MEDICS are intended strictly for laboratory research purposes only.

Size
Choose an option
CJC-1295 with DAC (2mg / 5mg)
Add to cart
Buy Now

CJC-1295 with DAC

CJC-1295 with DAC Research Peptide

CJC-1295 with DAC is a modified analogue of growth hormone releasing hormone (GHRH) designed to stimulate prolonged signaling activity in research models. The addition of the Drug Affinity Complex (DAC) helps extend the peptide’s half-life by allowing it to bind to circulating proteins within biological systems.

This structural modification allows researchers to study sustained hormone signaling mechanisms and the broader effects of GHRH-related peptides within experimental environments.

CJC-1295 peptides have become an important subject in modern peptide research due to their role in investigating endocrine system regulation and growth hormone pathway dynamics.

Scientific Background

Growth hormone releasing hormone (GHRH) peptides are part of a regulatory system that influences growth hormone secretion in biological systems.

Researchers studying CJC-1295 with DAC often investigate how modified GHRH analogues interact with endocrine receptors and hormonal signaling pathways.

Because of its extended stability compared to earlier peptide versions, CJC-1295 with DAC has become a focus in studies exploring:

  • Growth hormone signaling pathways

  • Endocrine system regulation

  • Metabolic research models

  • Hormonal feedback mechanisms

  • Peptide-receptor interaction studies

These areas remain active fields of investigation within peptide science.

Research Areas Associated With CJC-1295

In laboratory research environments, CJC-1295 with DAC may be studied in experimental models related to:

  • Growth hormone secretion signaling

  • Endocrine system interaction studies

  • Metabolic pathway research

  • Hormonal regulation models

  • Peptide receptor binding studies

Research continues to expand scientific understanding of modified GHRH analogues and their potential roles in endocrine signaling.

Product Specifications

Feature Details
Product Name CJC-1295 with DAC
Available Sizes 2mg and 5mg per vial
Form Lyophilized (freeze-dried) powder
Peptide Type GHRH analogue
Grade Research / Laboratory Grade
Manufacturer PEPTIDE MEDICS
Packaging Sterile sealed research vial
Application Laboratory research only

Storage Guidelines

Proper storage is recommended to maintain peptide stability and structural integrity.

Recommended storage practices include:

  • Store in a cool, dry environment

  • Refrigeration recommended for extended stability

  • Avoid excessive heat and direct sunlight

  • Handle using proper laboratory procedures

Correct storage conditions help preserve peptide integrity for research applications.

Research Use Disclaimer

All products distributed by PEPTIDE MEDICS are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, medical treatment, or veterinary use.

By purchasing from PEPTIDE MEDICS, customers confirm they are qualified professionals conducting legitimate scientific research.

Research References

Researchers interested in learning more about CJC-1295 and GHRH analogues may review scientific publications and peptide research literature available through databases such as:

  • PubMed

  • Endocrinology research journals

  • Peptide science publications

  • Hormonal signaling research studies

These resources provide additional insight into growth hormone releasing hormone analogues and endocrine pathway research.

CJC-1295 with DAC (2mg / 5mg) CJC-1295 with DAC (2mg / 5mg)

Additional Information

Size

2mg, 5mg

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC”

Your email address will not be published. Required fields are marked *